The University of Southampton
University of Southampton Institutional Repository

20 Gy external beam radiotherapy can stablise vision in patients with subfoveal choroidal neovascular membranes in the first 12 months

20 Gy external beam radiotherapy can stablise vision in patients with subfoveal choroidal neovascular membranes in the first 12 months
20 Gy external beam radiotherapy can stablise vision in patients with subfoveal choroidal neovascular membranes in the first 12 months
Abstract: : Purpose: To determine the effect of a higher dose of external beam radiotherapy on patients with subfoveal choroidal neovascular membranes (SCNV). Methods: 21 patients with SCNV as a result of Age Related Macular Degeneration (ARMD) were recruited and underwent teletherapy using 10 fractions of 2 Gy (total of 20Gy). All patients were followed-up at 3-month intervals for a period of 12 months and then at 6 monthly intervals thereafter. At each visit the Log Mar vision was recorded and fluorescein angiography was performed at 6 months intervals. A group of 24 patients with SCNV due to ARMD received no therapy and acted as controls. Results: The mean follow-up of patients was 17.2 months. The mean LogMAR visual acuity at diagnosis was 1.21 for the control group and 0.73 for the radiotherapy group. The mean logMAR visual acuity in the control group at 3 months, 6 months, 9 months and 12 months were 1.48, 1.47, 1.64 and 1.8 Log MAR units respectively. In the radiotherapy group, the mean LogMAR visual acuites were 0.76, 0.83, 0.86 and 0.9 LogMAR units. No adverse effects were noted in the radiotherapy treated group. The mean visual acuity loss at 12 months from the time at diagnosis was 0.1 logMAR units for the radiotherapy group and in the untreated control group it was 0.5 log MAR units. This difference in the visual acuity loss at 12 months from the start of treatment was found to be found to be statistically significant between the two groups (p <0.01, t-test). Conclusion: The data from this trial indicate that 20 Gy of external beam radiotherapy delivered in 10 fractions can stabilise visual loss for 12 months in patients with subretinal choroidal neovascular membranes, the finding supports work from others who use higher dose radiotherapy to treat SCNV.
0146-0404
Bhan, A
f42ae744-cc63-426c-9fd9-832abd3ee955
Hossain, Parwez
563de5fc-84ad-4539-9228-bde0237eaf51
Pagliarini, S
efd27c75-db1b-4b03-b3e3-fe12563ce3f8
Amoaku, W.M.
2ed85882-4d83-4223-8f26-459043a098a2
Sokal, M.
0d869edc-dbd6-4fcb-a31f-be053e407513
Bhan, A
f42ae744-cc63-426c-9fd9-832abd3ee955
Hossain, Parwez
563de5fc-84ad-4539-9228-bde0237eaf51
Pagliarini, S
efd27c75-db1b-4b03-b3e3-fe12563ce3f8
Amoaku, W.M.
2ed85882-4d83-4223-8f26-459043a098a2
Sokal, M.
0d869edc-dbd6-4fcb-a31f-be053e407513

Bhan, A, Hossain, Parwez, Pagliarini, S, Amoaku, W.M. and Sokal, M. (2002) 20 Gy external beam radiotherapy can stablise vision in patients with subfoveal choroidal neovascular membranes in the first 12 months. Investigative Ophthalmology & Visual Science, 43 (13).

Record type: Meeting abstract

Abstract

Abstract: : Purpose: To determine the effect of a higher dose of external beam radiotherapy on patients with subfoveal choroidal neovascular membranes (SCNV). Methods: 21 patients with SCNV as a result of Age Related Macular Degeneration (ARMD) were recruited and underwent teletherapy using 10 fractions of 2 Gy (total of 20Gy). All patients were followed-up at 3-month intervals for a period of 12 months and then at 6 monthly intervals thereafter. At each visit the Log Mar vision was recorded and fluorescein angiography was performed at 6 months intervals. A group of 24 patients with SCNV due to ARMD received no therapy and acted as controls. Results: The mean follow-up of patients was 17.2 months. The mean LogMAR visual acuity at diagnosis was 1.21 for the control group and 0.73 for the radiotherapy group. The mean logMAR visual acuity in the control group at 3 months, 6 months, 9 months and 12 months were 1.48, 1.47, 1.64 and 1.8 Log MAR units respectively. In the radiotherapy group, the mean LogMAR visual acuites were 0.76, 0.83, 0.86 and 0.9 LogMAR units. No adverse effects were noted in the radiotherapy treated group. The mean visual acuity loss at 12 months from the time at diagnosis was 0.1 logMAR units for the radiotherapy group and in the untreated control group it was 0.5 log MAR units. This difference in the visual acuity loss at 12 months from the start of treatment was found to be found to be statistically significant between the two groups (p <0.01, t-test). Conclusion: The data from this trial indicate that 20 Gy of external beam radiotherapy delivered in 10 fractions can stabilise visual loss for 12 months in patients with subretinal choroidal neovascular membranes, the finding supports work from others who use higher dose radiotherapy to treat SCNV.

Full text not available from this repository.

More information

Published date: December 2002

Identifiers

Local EPrints ID: 448136
URI: http://eprints.soton.ac.uk/id/eprint/448136
ISSN: 0146-0404
PURE UUID: cf4334c8-906d-4b92-b401-8c2fd6d201fe
ORCID for Parwez Hossain: ORCID iD orcid.org/0000-0002-3131-2395

Catalogue record

Date deposited: 12 Apr 2021 16:46
Last modified: 13 Apr 2021 01:41

Export record

Contributors

Author: A Bhan
Author: Parwez Hossain ORCID iD
Author: S Pagliarini
Author: W.M. Amoaku
Author: M. Sokal

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×